Drug Trial Radar · NCT01657019
Open Label Extension in Adults With Binge Eating Disorder (BED)
Last checked: Nov 19, 2026Latest source record: Jun 9, 2021 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
604
Actual
Start
Aug 21, 2012
Primary completion
Oct 21, 2014
Study completion Oct 21, 2014
Sponsor
- Lead sponsor
- ShireTakeda (TAK)
- Sponsor type
- Industry
- First posted
- Aug 3, 2012
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years, up to 55 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
To evaluate the safety and tolerability of SPD489 administered as a daily morning dose (50 or 70mg) in the treatment of moderate to severe binge eating disorder (BED) in adults
Conditions
- Binge Eating Disorder
Interventions
Lisdexamfetamine dimesylateDrug
50 or 70 mg administered orally, once a day for 52 weeks
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percentage of Participants With Treatment-Emergent Adverse Events (TEAEs) as a Measure of SafetyTime frame: 52 weeks
- Number of Participants With a Positive Response on The Columbia Suicide Severity Rating Scale (C-SSRS)Time frame: 53 weeks
Locations
89 sites in 3 countries. Site status is shown where the registry gives one.
Birmingham Research Group
Birmingham, Alabama
Radiant Research
Tucson, Arizona
Clinical Study Centers, LLC
Little Rock, Arkansas
Southwestern Research, Inc.
Beverly Hills, California
TRIMED Clinical Trials
Corona, California
Pharmacology Research Institute
Encino, California
Scripps Clinical Research Services
La Jolla, California
Pharmacology Research Institute
Los Alamitos, California
Pharmacology Research Institute
Newport Beach, California
Pacific Research Partners, LLC
Oakland, California
Excell Research, Inc
Oceanside, California
PCSD - Feighner Research
San Diego, California
Western Affiliated Research Institute, Inc
Denver, Colorado
Radiant Research, Inc
Denver, Colorado
Florida Clinical Research
Bradenton, Florida
Gulfcoast Clinical Research
Fort Myers, Florida
Clinical Neuroscience Solutions, Inc
Jacksonville, Florida
Fidelity Clinical Research, Inc
Lauderhill, Florida
Compass Research, LLC
Leesburg, Florida
Florida Clinical Research Center, LLC
Maitland, Florida
Scientific Clinical Research, Inc
North Miami, Florida
Clinical Neuroscience Solutions, Inc
Orlando, Florida
Miami Research Associates
South Miami, Florida
Atlanta Institute of Medicine and Research
Atlanta, Georgia
Neurotrials Research, Inc
Atlanta, Georgia
Capstone Clinical Research
Libertyville, Illinois
Baber Research Group
Naperville, Illinois
American Medical Research, Inc
Oak Brook, Illinois
Goldpoint Clinical Research, LLC
Indianapolis, Indiana
Deaconess Health Center
Newburgh, Indiana
Clinical Trials Technology, Inc
Prairie Village, Kansas
Cypress Medical Research Center, LLC
Wichita, Kansas
Louisana Research Associates, Inc
New Orleans, Louisiana
McLean Hospital
Belmont, Massachusetts
Boston Clinical Trials
Boston, Massachusetts
Activmed Practices & Research
Methuen, Massachusetts
Adams Clinical Trials, LLC
Watertown, Massachusetts
Rochester Center for Behavioral Medicine
Rochester Hills, Michigan
University of Minnesota
Minneapolis, Minnesota
St. Charles Psychiatric Associates-Midwest Research Group
Saint Charles, Missouri
Showing 40 of 89 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.